Oxygen enhancing membrane systems for implantable devices
The present invention relates generally to systems and methods for increasing oxygen availability to implantable devices. The preferred embodiments provide a membrane system configured to provide protection of the device from the biological environment and/or a catalyst for enabling an enzymatic reaction, wherein the membrane system includes a polymer formed from a high oxygen soluble material. The high oxygen soluble polymer material is disposed adjacent to an oxygen-utilizing source on the implantable device so as to dynamically retain high oxygen availability to the oxygen-utilizing source during oxygen deficits. Membrane systems of the preferred embodiments are useful for implantable devices with oxygen-utilizing sources and/or that function in low oxygen environments, such as enzyme-based electrochemical sensors and cell transplantation devices.
1. An implantable device for continuous in vivo measurement of an analyte concentration in a host, the device comprising:
a sensor configured for implantation in a host, the sensor configured to operatively connect with electronic circuitry configured to generate a signal associated with a concentration of an analyte in a host; and
a membrane located over the sensor and configured to control a flux of oxygen and the analyte therethrough, wherein the membrane comprises a material having an oxygen permeability of from about 5 Barrers to about 1000 Barrers.
2. The device of claim 1 , wherein the material comprises a copolymer comprising a fluorocarbon segment.
3. The device of claim 2 , wherein the fluorocarbon segment is perfluorinated.
4. The device of claim 2 , wherein the copolymer further comprises a polycarbonate segment.
5. The device of claim 2 , wherein the copolymer has an oxygen solubility of about 50-volume %.
6. The device of claim 2 , wherein the membrane comprises a blend, wherein the blend comprises the copolymer and a hydrophilic polymer.
7. The device of claim 6 , wherein the hydrophilic polymer is selected from the group consisting of polyvinylpyrrolidone, polyhydroxyethyl methacrylate, polyvinylalcohol, polyacrylic acid, polyethers, and copolymers thereof.
8. The device of claim 1 , wherein the membrane has a thickness of from about 3 microns to about 65 microns.
9. The device of claim 1 , wherein the membrane comprises an enzyme domain, wherein the enzyme domain comprises an enzyme configured to react with the analyte.
10. The device of claim 1 , wherein the membrane is configured to limit or block passage of interfering species therethrough.
11. The device of claim 1 , wherein the membrane is configured to provide protection to the sensor from a biological environment.
12. The device of claim 1 , wherein the material has an oxygen permeability of at least about 10 Barrers.
13. The device of claim 1 , wherein the material has an oxygen permeability of at least about 100 Barrers.
14. The device of claim 1 , wherein the material has an oxygen permeability of at least about 500 Barrers.
15. The device of claim 1 , wherein the material has an oxygen permeability of at least about 800 Barrers.
16. The device of claim 1 , wherein the analyte is glucose.
17. The device of claim 1 , wherein the membrane has an oxygen permeability from about 30 Barrers to about 1000 Barrers.
18. The device of claim 1 , wherein the membrane comprises a domain that has an oxygen permeability from about 30 Barrers to about 1000 Barrers.
19. The device of claim 1 , wherein the material has an oxygen solubility that is from about three times to about ten times greater than an oxygen solubility of aqueous media.
20. An implantable device for continuous in vivo measurement of a glucose concentration in a host, the device comprising:
a sensor operatively connected to electronic circuitry configured to generate a signal associated with a concentration of glucose in a host; and
a membrane located over the sensor and configured to control a flux of oxygen and glucose therethrough, wherein the membrane comprises a material having an oxygen permeability of from about 5 Barrers to about 1000 Barrers, wherein the material comprises a copolymer comprising a fluorocarbon segment and a polycarbonate segment, wherein the membrane has a thickness of from about 3 microns to about 65 microns, and wherein the membrane comprises an enzyme domain comprising an enzyme configured to react with glucose.
21. The device of claim 20 , wherein the material has an oxygen solubility that is from about three times to about ten times greater than an oxygen solubility of aqueous media.